These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18951818)

  • 21. Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial.
    Kwan P; Brodie MJ; Kälviäinen R; Yurkewicz L; Weaver J; Knapp LE
    Lancet Neurol; 2011 Oct; 10(10):881-90. PubMed ID: 21889410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregabalin add-on for drug-resistant partial epilepsy.
    Lozsadi D; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005612. PubMed ID: 18254084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.
    Baulac M; Leon T; O'Brien TJ; Whalen E; Barrett J
    Epilepsy Res; 2010 Sep; 91(1):10-9. PubMed ID: 20696552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures.
    Arroyo S; Anhut H; Kugler AR; Lee CM; Knapp LE; Garofalo EA; Messmer S;
    Epilepsia; 2004 Jan; 45(1):20-7. PubMed ID: 14692903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study.
    Yamauchi T; Kaneko S; Yagi K; Sase S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):507-15. PubMed ID: 16884455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies.
    Steinhoff BJ; Ben-Menachem E; Ryvlin P; Shorvon S; Kramer L; Satlin A; Squillacote D; Yang H; Zhu J; Laurenza A
    Epilepsia; 2013 Aug; 54(8):1481-9. PubMed ID: 23663001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregabalin: new drug. Very similar to gabapentin.
    Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS).
    Ryvlin P; Kälviäinen R; Von Raison F; Giordano S; Emir B; Chatamra K
    Eur J Neurol; 2010 May; 17(5):726-32. PubMed ID: 20113339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
    French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
    Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
    Zaccara G; Almas M; Pitman V; Knapp L; Posner H
    Epilepsia; 2014 Jul; 55(7):1048-57. PubMed ID: 24902473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
    Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T;
    Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
    French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
    Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports.
    Hitiris N; Barrett JA; Brodie MJ
    Epilepsy Behav; 2006 Mar; 8(2):418-21. PubMed ID: 16446121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.